In the latest market close, Oscar Health, Inc. (OSCR) saw a -1.57% movement to $15.65, lagging behind the S&P 500’s 0.88% gain. Shares had gained 16.91% in the past month, outperforming the Finance sector. Earnings are expected to be reported on February 4, 2025, with an estimated EPS of -$0.58 and revenue of $2.46 billion.

Analyst estimates for Oscar Health, Inc. are closely watched, with recent adjustments reflecting short-term business dynamics. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), currently rates OSCR as a #3 (Hold). The stock is trading at a Forward P/E ratio of 20.78, indicating a premium compared to the industry average.

Oscar Health, Inc. has a PEG ratio of 0.64, lower than the industry average of 1.05, reflecting expected earnings growth. The Insurance – Multi line industry, to which OSCR belongs, has a Zacks Industry Rank of 142, placing it in the bottom 44% of all industries. Top 50% rated industries typically outperform the bottom half by 2 to 1.

Experts have identified 7 elite stocks as the “Most Likely for Early Price Pops.” These stocks have historically outperformed the market, with an average annual gain of +24.1% since 1988. Investors can access these hand-picked stocks for potential gains in the next 30 days. Visit Zacks.com for more stock-moving metrics and recommendations.

Read more at Nasdaq: Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note